Abbott (ABT) Tops Q4 EPS by 2c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Abbott Labs (ABT) PT Raised to $72 at Cowen
July 19, 2018 8:23 AM EDTCowen raised its price target on Abbott Labs (NYSE: ABT) to $72.00 (from $68.00) while maintaining a Outperform rating following solid Q2 results.
Analyst Joshua Jennings notes organic growth was 8%, versus 6%-7% guidance range and also north of the 7% organic rate shown in 1Q. Also, guidance was raised despite a strong dollar.
... MoreAbbott Labs (ABT) PT Raised to $70 at RBC Capital
July 19, 2018 7:16 AM EDTRBC Capital raised its price target on Abbott Labs (NYSE: ABT) to $70.00 (from $67.00) while maintaining a Outperform rating.
Analyst Glenn Novarro said results again demonstrated powerful momentum across all four segments, especially outside the U.S.
... MoreAbbott Labs (ABT) PT Raised to $70 at Evercore ISI
July 18, 2018 12:19 PM EDTEvercore ISI raised its price target on Abbott Labs (NYSE: ABT) to $70.00 (from $66.00) while maintaining a Outperform rating.
What analyst Vijay Kumar liked in the quarter:
8% organic topline came in above ST and whisper expectationsNutrition came in above (~2% above ST) and... More